Category

IBTA News

IBTA e-News September 2019 now out

By IBTA News

[30 September 2019] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include news that researchers conducting the phase 3 CeTeG/NOA-09 study saw significantly longer overall survival for those patients who received lomustine-temozolomide therapy compared to those on standard temozolomide alone.

Read More

let us know you agree to cookies

The IBTA website uses cookies to give you the best online experience in accordance with our cookies policy. If you are happy, please confirm by clicking the 'Accept' button below.